AccuraGen China passed the proficiency test of 2019-nCoV nucleic acid testing (NCCL)
Recently, NCCL announced the results of‘2019-nCoV nucleic acid detection capability verification’. Shanghai YunshengMedical Laboratory (fully owned subsidiary of AccuraGen Holdings) passed thequality evaluation with ‘fluorescent real-time PCR’. The test results arecompletely consistent with the standards.
Atotal of 12 quality assessment samples were issued this time, and a total of844 laboratories submitted valid test results; of which 701 passed (83.1%) and143 failed (16.9%).